
Patients in Southern California are receiving diagnoses and treatment plans generated by artificial intelligence through Akido Labs' ScopeAI proprietary system, according to MIT.
The startup uses large language models to transcribe conversations between patients and medical assistants, suggest potential diagnoses, and propose treatment steps that physicians later review and approve.